Investigating how proteins form amyloid fibrils and finding ways to inhibit this process
Protein Amyloid Formation and Inhibition Studied by Mass Spectrometry
['FUNDING_OTHER'] · UNIVERSITY OF MASSACHUSETTS AMHERST · NIH-10915452
This study is looking at how certain proteins, like β-2-microglobulin, form harmful clumps that can lead to serious health issues, especially for people on hemodialysis, and aims to find ways to stop this process to help create better treatments for these conditions.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MASSACHUSETTS AMHERST (nih funded) |
| Locations | 1 site (HADLEY, UNITED STATES) |
| Trial ID | NIH-10915452 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding the formation of amyloid fibrils, which are linked to serious diseases like Alzheimer's and type II diabetes. By using advanced mass spectrometry techniques, the researchers aim to uncover the early stages of amyloid formation, particularly for the protein β-2-microglobulin, which is known to cause complications in patients undergoing hemodialysis. The goal is to develop effective inhibitors that can prevent the formation of these harmful fibrils, potentially leading to new treatments for conditions currently lacking effective therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with conditions associated with amyloid fibril formation, such as Alzheimer's disease, type II diabetes, and those undergoing hemodialysis.
Not a fit: Patients without amyloid-related diseases or those not affected by the conditions being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for amyloid-related diseases, improving patient outcomes and quality of life.
How similar studies have performed: Other research has shown promise in understanding amyloid formation and developing inhibitors, but this specific approach using advanced mass spectrometry is relatively novel.
Where this research is happening
HADLEY, UNITED STATES
- UNIVERSITY OF MASSACHUSETTS AMHERST — HADLEY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VACHET, RICHARD W — UNIVERSITY OF MASSACHUSETTS AMHERST
- Study coordinator: VACHET, RICHARD W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Adult-Onset Diabetes Mellitus, Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease